Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationHematopoietic Stem Cell MobilizationCombined Modality TherapyTransplantation ConditioningAntineoplastic Combined Chemotherapy ProtocolsTransplantation, HomologousMelphalanCyclophosphamideGranulocyte Colony-Stimulating FactorAntigens, CD34LeukapheresisHematologic NeoplasmsStem Cell TransplantationBlood Component RemovalTreatment OutcomeMultiple MyelomaLymphoma, Non-HodgkinGraft vs Host DiseaseStem CellsMyeloablative AgonistsHematopoietic Stem CellsBusulfanGraft SurvivalBone Marrow TransplantationEtoposideThiotepaAntineoplastic Agents, AlkylatingRemission InductionSalvage TherapyRecurrenceCarmustineCytophagocytosisCord Blood Stem Cell TransplantationIfosfamideAntineoplastic AgentsHematopoiesisDisease-Free SurvivalVincristineAmyloidosisCytarabineHodgkin DiseaseTransplantation ChimeraNeoplasmsSurvival RateTissue DonorsRetrospective StudiesSurvival AnalysisTime FactorsDoxorubicinWhole-Body IrradiationHistocompatibility TestingHistocompatibilityInfectionLymphoma, T-CellPlatelet CountCarboplatinBlood Cell CountTransplantation, IsogeneicPOEMS SyndromeLeukemia, Myeloid, AcutePrednisoneImmunosuppressive AgentsLeukemiaFollow-Up StudiesDexamethasoneVidarabineRecombinant ProteinsProspective StudiesLymphomaBone Marrow PurgingBlood CellsEmbryonic Stem CellsFatal OutcomeCytomegalovirus InfectionsFeasibility StudiesGraft vs Leukemia EffectMyelodysplastic SyndromesAdult Stem CellsImmunophenotypingMesenchymal Stem Cell TransplantationLymphocyte DepletionHematologic DiseasesLeukemia, Myelogenous, Chronic, BCR-ABL PositiveChemotherapy, AdjuvantAnemia, AplasticBreast NeoplasmsPrognosisT-LymphocytesBlood Transfusion, AutologousBone MarrowHLA AntigensLiver TransplantationFlow CytometryPrecursor Cell Lymphoblastic Leukemia-LymphomaBlood DonorsLeukocytes, MononuclearCell SeparationOpportunistic Infections